Skip to main content

Table 1 Distribution and characterisation of the groups

From: Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy

 

Controls

Tuberculosis patients

  

A: Before treatment

B: Subgroup;

follow-up analyses

Number

216

108

71

Gender (%) (females, males)

33.5/66.5

33.3/66.7

27.8/72.2

Age, Mean ± SD

41.1 ± 15.5

40.1 ± 14.8

40.4 ± 15.0

Smoking, no/yes (%)

53.2/46.8

59.5/40.5

62.5/37.5

BCG scar, absent/present/unknown (%),

75.2/18.3/6.4

91/8.1/0.9

90.3/9.7/0

Reported allergy, n (%)

14 (6.4)

21 (18.9)

13 (18.1)

Weeks of TB symptoms

Mean ± SD

 

10.5 ± 5.7

10.4 ± 5.9

  1. BCG = Bacillus Calmette-Gu, rin, A: These patients were included in the analyses between tuberculosis patients and healthy controls. B: The subgroup consisted of 71 patients which were followed-up after treatment. These patients were included in paired-analyses concerning before and after tuberculosis treatment.